{"url":"https://lda.senate.gov/api/v1/filings/b4f2ad71-2b70-4e63-829c-e39bf939d8dc/","filing_uuid":"b4f2ad71-2b70-4e63-829c-e39bf939d8dc","filing_type":"2A","filing_type_display":"2nd Quarter - Amendment","filing_year":2021,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b4f2ad71-2b70-4e63-829c-e39bf939d8dc/print/","filing_document_content_type":"text/html","income":"15000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gaurav Parikh","dt_posted":"2023-10-18T15:50:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1413 20th Street South","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22202","registrant":{"id":401105260,"url":"https://lda.senate.gov/api/v1/registrants/401105260/","house_registrant_id":null,"name":"SIGNIFICANT CONSULTING, LLP","description":"consulting firm","address_1":"1413 20th Street South","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22202","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GAURAV PARIKH","contact_telephone":"+1 202-590-8424","dt_updated":"2024-04-15T17:00:25.746866-04:00"},"client":{"id":209712,"url":"https://lda.senate.gov/api/v1/clients/209712/","client_id":24,"name":"STONINGTON GLOBAL (OBO, SORRENTO THERAPEUTICS)","general_description":"Consulting Firm, Biopharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-10-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"COVID Testing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72788,"prefix":null,"prefix_display":null,"first_name":"GAURAV","nickname":null,"middle_name":"PRADEEP","last_name":"PARIKH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"COVID","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72788,"prefix":null,"prefix_display":null,"first_name":"GAURAV","nickname":null,"middle_name":"PRADEEP","last_name":"PARIKH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}